Long-Term Management of Chronic GERD

Initial Approach and Shared Decision-Making

• The American Gastroenterological Association recommends developing a comprehensive care plan with the patient using shared decision-making that addresses investigation, therapy selection with risks/benefits, and long-term management including possible de-escalation 1, 4, 5
• Patients with chronic GERD should receive standardized education on GERD mechanisms, weight management, dietary behaviors, relaxation strategies, and brain-gut axis relationships 1, 6, 2
• Emphasize PPI safety to address patient concerns about long-term use 1, 4, 5

Establishing the Diagnosis for Long-Term Therapy

• Objective testing is essential to confirm GERD and guide management when planning long-term PPI therapy beyond 12 months 1, 4, 5
• Offer endoscopy with prolonged wireless pH monitoring (96-hour preferred) off PPI therapy to establish appropriate use of long-term therapy 1, 4, 5, 7
• Complete endoscopic evaluation should assess for erosive esophagitis (Los Angeles classification), hiatal hernia, and Barrett's esophagus 1, 4, 5

Phenotype-Based Long-Term Management Strategy

• Patients with non-severe GERD should be titrated to the lowest effective PPI dose or weaned to on-demand therapy 1, 4, 5
• Consider on-demand therapy with H2-blockers or antacids once symptoms are controlled 6, 2, 3
• Implement aggressive lifestyle modifications including weight management 6, 2, 3
• If pH monitoring shows physiologic acid exposure, discontinue PPI and consider neuromodulators or behavioral interventions for functional esophageal disorder 1, 4, 5, 7

Management of Refractory Symptoms

• Perform 24-hour pH-impedance monitoring ON PPI therapy to determine mechanism (acid reflux vs. non-acid reflux vs. hypersensitivity) 7
• Consider esophageal physiologic testing (high-resolution manometry, esophagram) to assess candidacy for intervention 6, 2, 3
• Evaluate for alternative diagnoses including small intestinal bacterial overgrowth, malabsorption, or functional disorders 7
• Avoid empiric rotation of PPIs, as this has low yield and delays correct diagnosis 7
• Consider neuromodulator therapy (low-dose tricyclic antidepressants) combined with cognitive-behavioral therapy, gut-directed hypnotherapy, or diaphragmatic breathing techniques 6, 2, 3, 7

Adjunctive Therapies for All Phenotypes

• Weight management for overweight/obese patients 1, 6, 2
• Cognitive behavioral therapy or gut-directed hypnotherapy as indicated 6, 2, 3
• Neuromodulators for visceral hypersensitivity when appropriate 6, 2, 3

Escalation to Surgical/Endoscopic Intervention

• Consider anti-reflux procedures for patients with confirmed severe GERD who remain symptomatic despite optimized medical therapy 6, 2, 3
• Complete esophageal physiologic testing before intervention to assess candidacy 6, 2, 3

Critical Pitfalls to Avoid

• Do not continue long-term PPI without objective confirmation of GERD diagnosis 1, 4, 5
• Do not assume GERD is confirmed based solely on symptom improvement with PPI, as this may reflect placebo effect 7
• Do not ignore atypical gastrointestinal symptoms that may require independent evaluation 7
• Do not wean PPIs in patients with documented erosive esophagitis, Barrett's esophagus, or severe GERD phenotype 6, 2, 3